Acesso livre
Acesso livre

Emergências e UTI Pediátrica

Estudo randomizado | Em neonatos a termo e próximos do termo, tratamento medicamentoso de todas as convulsões detectadas por meios clínicos e eletrográficos não foi associado com menores taxas de morte ou incapacidade em 2 anos, em comparação com o tratamento apenas das convulsões clinicamente detectadas.

13 Jan, 2022 | 20:54h

Effect of Treatment of Clinical Seizures vs Electrographic Seizures in Full-Term and Near-Term Neonates: A Randomized Clinical Trial – JAMA Network Open

Comentários:

Should we treat electrographic seizures? – Neonatal Research

Subclinical Electrographic Seizures in the Newborn—Is More Treatment Better? – JAMA Network Open

Neonatal Seizures: Little Difference Between EEG/Clinical Treatment – Physician’s Weekly

 

Comentário no Twitter

 


Estudo internacional identifica preditores de desfechos graves em crianças com COVID-19.

13 Jan, 2022 | 12:09h

Comunicado de imprensa: International study identifies predictors of severe outcomes in children with COVID-19 – University of Calgary

Estudo original: Outcomes of SARS-CoV-2–Positive Youths Tested in Emergency Departments: The Global PERN–COVID-19 Study – JAMA Network Open


Diretriz NICE | Febre em menores de 5 anos: avaliação e tratamento.

17 Dez, 2021 | 12:12h

Fever in under 5s: assessment and initial management – National Institute for Health and Care Excellence

Conteúdo relacionado: AAP Guideline: Evaluation and management of well-appearing febrile infants 8 to 60 days old.


Sepse em crianças: estado da arte do tratamento.

16 Dez, 2021 | 12:53h

Sepsis in children: state-of-the-art treatment – Therapeutic Advances in Infectious Disease


Antibióticos em crianças gravemente doentes – Uma revisão narrativa sobre os diferentes aspectos de uma abordagem racional.

16 Dez, 2021 | 12:52h

Antibiotics in critically ill children—a narrative review on different aspects of a rational approach – Pediatric Research


Posicionamento científico | Diagnóstico, tratamento e prevenção da ingestão de baterias na infância.

15 Dez, 2021 | 12:33h

Diagnosis, Management, and Prevention of Button Battery Ingestion in Childhood: A European Society for Paediatric Gastroenterology Hepatology and Nutrition Position Paper – Journal of Pediatric Gastroenterology and Nutrition

Resumo visual: Diagnosis, Management, and Prevention of Button Battery Ingestion in Childhood

 

Comentário no Twitter (fio – clique para saber mais)

 


Estudo randomizado | Em bebês prematuros com síndrome da angústia respiratória aguda, a administração de surfactante via cateter fino não melhora os desfechos.

15 Dez, 2021 | 12:28h

Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)

Editorial: Minimally Invasive Surfactant Therapy to Prevent Bronchopulmonary Dysplasia in Extremely Preterm Infants – JAMA (gratuito por tempo limitado)

Vídeo: Demonstration of the Hobart Method of Minimally Invasive Surfactant Therapy in a Resuscitation Manikin Equivalent to a 27-Week Gestation 1-kg Preterm Infant – JAMA


Estudo retrospectivo | Perfis de suscetibilidade antibiótica entre patógenos da sepse neonatal precoce (SNP) – “A ampla maioria dos patógenos da SNP são suscetíveis à combinação de ampicilina com gentamicina.”

14 Dez, 2021 | 16:04h

Antimicrobial Susceptibility Profiles Among Neonatal Early-onset Sepsis Pathogens – The Pediatric Infectious Disease Journal

 

Comentário no Twitter

 


Série de casos com 139 adolescentes e adultos jovens com suspeita de miocardite após vacina de mRNA mostrou que a maioria deles teve curso clínico leve e resolução rápida dos sintomas.

7 Dez, 2021 | 11:46h

Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults – Circulation

Comunicado de imprensa: Young people recover quickly from rare myocarditis side effect of COVID-19 vaccine – American Heart Association


Revisão de 4.470 casos de síndrome inflamatória multissistêmica em crianças nos EUA.

7 Dez, 2021 | 11:40h

Multisystem Inflammatory Syndrome in Children—United States, February 2020–July 2021 – Clinical Infectious Diseases

Conteúdos relacionados:

WHO issues guidelines on the treatment of children with multisystem inflammatory syndrome associated with COVID-19.

An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.

Ten Things to Know About Multisystem Inflammatory Syndrome in Children (MIS-C).

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.

Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, there was no evidence that recovery differed after primary treatment with intravenous immune globulin (IVIG) alone, IVIG plus glucocorticoids, or glucocorticoids alone.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, initial treatment with intravenous immune globulin (IVIG) plus glucocorticoids was associated with a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

Cohort study showed that the incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) was 316 persons per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. The incidence was higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons.

Cohort study showed good recovery for most children 6 months after Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) associated with SARS-CoV-2.

Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When

Neurologic involvement in children and adolescents with COVID-19 or Multisystem Inflammatory Syndrome

Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children

Differences in characteristics and outcomes of children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) vs. severe acute COVID-19

Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)

SR: Multisystem inflammatory syndrome in children related to COVID-19

Observational study: The combination of Immunoglobulins + Methylprednisolone was associated with a better course of fever compared to Immunoglobulins alone in Multisystem Inflammatory Syndrome in children

ACR Guidance for pediatric patients with multisystem inflammatory syndrome in children associated with SARS‐CoV‐2

New systematic review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 infection summarizes the clinical features, management, and outcomes of the disease, showing favorable outcomes for the majority of children


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.